(Q28246557)

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Improving the efficacy of antibody-based cancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Anatomy of the antibody molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Identification of specificity-determining residues in antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Development of a minimally immunogenic variant of humanized anti-carcinoma monoclonal antibody CC49.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Reshaping human antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Replacing the complementarity-determining regions in a human antibody with those from a mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

The Protein Data Bank: a computer-based archival file for macromolecular structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Protein Data Bank archives of three-dimensional macromolecular structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

The EMBL Nucleotide Sequence Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

The Protein Information Resource: an integrated public resource of functional annotation of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

A humanized antibody that binds to the interleukin 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Humanization of a mouse monoclonal antibody by CDR–grafting: the importance of framework residues on loop conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Identification of framework residues required to restore antigen binding during reshaping of a monoclonal antibody against the glycoprotein gB of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Surface plasmon resonance-based competition assay to assess the sera reactivity of variants of humanized antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Adaptation of a surface plasmon resonance biosensor with microfluidics for use with small sample volumes and long contact times

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

Application of 1,1'-carbonyldiimidazole-activated agarose for the purification of proteins. II. The use of an activated matrix devoid of additional charged groups for the purification of thyroid proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

X-ray crystallography of antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.01.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2005.01.003

1 reference

Consolidated OpenCitations Corpus – April 2017

release_7v6c4cygt5gr3e7t7uaubn5avm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7v6c4cygt5gr3e7t7uaubn5avm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15848072

1 reference

Consolidated OpenCitations Corpus – April 2017